STTK

STTK

USD

Shattuck Labs Inc. Common Stock

$1.930-0.030 (-1.531%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.960

最高

$2.075

最低

$1.858

交易量

0.10M

公司基本面

市值

92.5M

行業

生物科技

國家

United States

交易統計

平均交易量

0.81M

交易所

NMS

貨幣

USD

52週範圍

最低 $0.692當前 $1.930最高 $2.705

相關新聞

Analyst Upgrades

Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4

Wedbush analyst David Nierengarten initiates coverage on Shattuck Labs with a Outperform rating and announces Price Target of $4.

查看更多
Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4
GlobeNewswire

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma

查看更多
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
GlobeNewswire

Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease

– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to

查看更多
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease